関連する実験動画
Updated: Jul 16, 2026

07:42
Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
Li-Fraumeni症候群におけるヘテロジゴトの生殖線hCHK2変異は,Li-Fraumeni症候群において発生する
D W Bell1, J M Varley, T E Szydlo
1Massachusetts General Hospital Center for Cancer Risk Analysis and Harvard Medical School, Building 149, Charlestown, MA 02129, USA.
まとめ
ヒトのチェックポイントキナーゼ2 (hCHK2) 遺伝子の変異は,遺伝的な癌性傾向であるLi-Fraumeni症候群と関連しています. これは,hCHK2が腫瘍抑制剤として作用し,肉腫,乳がん,脳がんのリスクに影響を及ぼすことを示唆しています.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- hCHK2遺伝子は,DNA損傷後のミトーシスの予防に不可欠なG2チェックポイントキナーゼをコードする.
- イーストの同種Cds1とRad53は,DNA損傷反応において同様の役割を果たします.
- Li-Fraumeni症候群は,典型的にはTP53変異と関連している遺伝性がんの傾向です.
研究 の 目的:
- 遺伝性がんの予備性におけるhCHK2遺伝子の役割を調査する.
- hCHK2変異がLi-Fraumeni症候群と関連しているかどうかを判断する.
- hCHK2,p53,およびG2DNAダメージチェックポイントの間のリンクを探求する.
主な方法:
- hCHK2遺伝子の変異を特定するための生殖細胞DNA分析.
- Li-Fraumeni症候群の患者の臨床評価について.
- イーストのDNA損傷反応経路との比較分析.
主要な成果:
- Li-Fraumeni症候群の患者で,hCHK2の異体性生殖系変異が特定されました.
- これらの変異は,サルコマ,乳がん,脳腫瘍を含む特定の癌への予備性を与える.
- この発見は,hCHK2の機能と,がんにおけるp53の確立された役割とを関連付けています.
結論:
- hCHK2遺伝子は腫瘍抑制剤として機能する.
- hCHK2の生殖線変異は,Li-Fraumeni症候群および関連する癌に寄与する.
- この研究は,G2チェックポイント経路をp53とhCHK2.2経由でヒトのがん傾向に結びつけています.
関連する概念動画
Mutations
Overview
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Sex Linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

